|
Martin A, Calvo D, Llamas P, Roldan V, Cozar R, Fernandez de Simon A, Avila P, Del Arco C, Arbelo E, Pinera P, Coll-Vinent B. Emergency department management of atrial fibrillation: 2023 consensus from the Spanish Society of Emergency Medicine (SEMES), the Spanish Society of Cardiology (SEC), and the Spanish Society of Thrombosis and Hemostasis (SETH). Emergencias. 2023 Oct;35(5):359-377. doi: 10.55633/s3me/E027.2023. Erratum In: Emergencias. 2023 Dec;35(6):479-480. Emergencias. 2024 Jan;36(1):80. doi: 10.55633/s3me/005.2024. English, Spanish. PubMed PMID: 37801418.
AÑO: 2023; IF: 5.4
|
37801418
|
Rivera-Caravaca JM, Roldan V, Martinez-Montesinos L, Vicente V, Lip GYH, Marin F. The Atrial Fibrillation Better Care (ABC) Pathway and Clinical Outcomes in Patients with Atrial Fibrillation: the Prospective Murcia AF Project Phase II Cohort. J Gen Intern Med. 2023 Feb;38(2):315-323. doi: 10.1007/s11606-022-07567-5. Epub 2022 Apr 11. PubMed PMID: 35411538; PubMed Central PMCID: PMC9905403.
AÑO: 2023; IF: 4.3
|
|
Soler-Espejo E, Esteve-Pastor MA, Rivera-Caravaca JM, Roldan V, Marin F. Reducing bleeding risk in patients on oral anticoagulation therapy. Expert Rev Cardiovasc Ther. 2023 Jul-Dec;21(12):923-936. doi: 10.1080/14779072.2023.2275662. Epub 2023 Dec 13. PubMed PMID: 37905915.
AÑO: 2023; IF: 2.0
|
|
Pagan-Escribano J, Corral J, Minano A, Padilla J, Roldan V, Hernandez-Vidal MJ, Lozano J, de la Morena-Barrio I, Vicente V, Lozano ML, Herranz MT, de la Morena-Barrio ME. Factor XI in Carriers of Antiphospholipid Antibodies: Elevated Levels Associated with Symptomatic Thrombotic Cases, While Low Levels Linked to Asymptomatic Cases. Int J Mol Sci. 2023 Nov 13;24(22):16270. doi: 10.3390/ijms242216270. PubMed PMID: 38003459; PubMed Central PMCID: PMC10670960.
AÑO: 2023; IF: 4.9
|
|
Esteve-Pastor MA, Rivera-Caravaca JM, Roldan V, Sanmartin Fernandez M, Arribas F, Masjuan J, Barrios V, Cosin-Sales J, Freixa-Pamias R, Recalde E, Perez-Cabeza AI, Manuel Vazquez Rodriguez J, Rafols Priu C, Anguita Sanchez M, Lip GYH, Marin F. Predicting performance of the HAS-BLED and ORBIT bleeding risk scores in patients with atrial fibrillation treated with Rivaroxaban: Observations from the prospective EMIR Registry. Eur Heart J Cardiovasc Pharmacother. 2022 Dec 15;9(1):38-46. doi: 10.1093/ehjcvp/pvac060. PubMed PMID: 36318457.
AÑO: 2022; IF: 7.1
|